Trials / Completed
CompletedNCT04334902
Evaluation of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images
An Open Label, Multicenter, Retrospective, Pivotal Trial to Evaluate the Efficacy of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 221 (actual)
- Sponsor
- Heuron Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
mPDia is a software that has been pre-learned based on a neurodegenerative parkinsonism diagnosis model using Nigrosome 1 MRI images, and clinical decision support system for diagnosing neurodegenerative parkinsonism by automatically analyzing Nigrosome 1 MRI images by assisting the medical team. The specific aims of this study are to evaluate efficacy of mPDia for neurodegenerative Parkinsonism compared to the sensitivity and specificity levels of 18F FP-CIT PET/CT which is currently used to diagnose neurodegenerative parkinsonism.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | mPDia | Clinical decision support system for diagnosing neurodegenerative parkinsonism |
Timeline
- Start date
- 2020-03-13
- Primary completion
- 2020-06-24
- Completion
- 2020-10-30
- First posted
- 2020-04-06
- Last updated
- 2025-10-29
- Results posted
- 2025-10-29
Locations
10 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04334902. Inclusion in this directory is not an endorsement.